WHO laboratory validation of Xpert® CT/NG and Xpert® TV on the GeneXpert system verifies high performances
- PMID: 30456870
- PMCID: PMC6488022
- DOI: 10.1111/apm.12902
WHO laboratory validation of Xpert® CT/NG and Xpert® TV on the GeneXpert system verifies high performances
Abstract
Effective tests for diagnosis of sexually transmitted infections (STIs), used point of care to inform treatment and management decisions, are urgently needed. We evaluated the analytical sensitivity and specificity of the Xpert® CT/NG and Xpert® TV tests, examining 339 samples spiked with phenotypically and/or genetically diverse strains of Neisseria gonorrhoeae, Chlamydia trachomatis, and Trichomonas vaginalis, and other related species that may cross-react. The APTIMA Combo 2 test and APTIMA TV test were used as reference tests. The analytical sensitivity for all three agents in the Xpert® CT/NG and Xpert® TV tests was ≤102 genome equivalents/reaction. The analytical specificity of both tests was high. False-positive results were identified in the Xpert® TV test when challenging with high concentrations of Trichomonas tenax, Trichomonas gallinae, Trichomonas stableri, and Trichomonas aotus. However, the clinical relevance of these cross-reactions can likely be neglected, because these species have not been identified in urogenital samples from humans. In conclusion, the analytical sensitivity and specificity of the user-friendly Xpert® CT/NG and Xpert® TV tests on the GeneXpert system were high. The results support the use of specimens from also extra-genital sites, for example, pharynx and rectum. However, appropriate clinical validations are additionally required.
Keywords: Chlamydia trachomatis; Neisseria gonorrhoeae; Trichomonas vaginalis; GeneXpert; Xpert® CT/NG; Xpert® TV; point of care.
© 2018 APMIS. Published by John Wiley & Sons Ltd.
Similar articles
-
High prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and particularly Trichomonas vaginalis diagnosed using US FDA-approved Aptima molecular tests and evaluation of conventional routine diagnostic tests in Ternopil, Ukraine.APMIS. 2019 Sep;127(9):627-634. doi: 10.1111/apm.12975. APMIS. 2019. PMID: 31225920
-
Standardised protocol for a prospective international multicentre clinical-based evaluation of point-of-care tests for the screening of genital and extragenital chlamydial and gonococcal infections in men who have sex with men and for the screening of genital chlamydial, gonococcal and Trichomonas vaginalis infections in at risk women.BMJ Open. 2024 Jun 16;14(6):e073565. doi: 10.1136/bmjopen-2023-073565. BMJ Open. 2024. PMID: 38885995 Free PMC article.
-
Diagnostic accuracy of the Xpert CT/NG and OSOM Trichomonas Rapid assays for point-of-care STI testing among young women in South Africa: a cross-sectional study.BMJ Open. 2019 Feb 19;9(2):e026888. doi: 10.1136/bmjopen-2018-026888. BMJ Open. 2019. PMID: 30782948 Free PMC article. Clinical Trial.
-
Quality control and external quality assessment for the independent clinic-based evaluation of point-of-care testing to detect Chlamydia trachomatis, Neisseria gonorrhoeae and Trichomonas vaginalis in eight countries.BMC Infect Dis. 2024 Feb 29;24(Suppl 1):203. doi: 10.1186/s12879-024-09057-x. BMC Infect Dis. 2024. PMID: 38418947 Free PMC article.
-
APTIMA® Trichomonas vaginalis, a transcription-mediated amplification assay for detection of Trichomonas vaginalis in urogenital specimens.Expert Rev Mol Diagn. 2011 Sep;11(7):679-88. doi: 10.1586/erm.11.53. Expert Rev Mol Diagn. 2011. PMID: 21902528 Review.
Cited by
-
Multiresistant Neisseria gonorrhoeae: a new threat in second decade of the XXI century.Med Microbiol Immunol. 2020 Apr;209(2):95-108. doi: 10.1007/s00430-019-00651-4. Epub 2019 Dec 4. Med Microbiol Immunol. 2020. PMID: 31802195 Free PMC article. Review.
-
The Clinico-Epidemiological Profile of Patients with Gonorrhoea and Challenges in the Management of Neisseria gonorrhoeae Infection in an STI clinic, Ternopil, Ukraine (2013-2018).J Med Life. 2020 Jan-Mar;13(1):75-81. doi: 10.25122/jml-2019-0170. J Med Life. 2020. PMID: 32341705 Free PMC article.
-
Diagnosis and Management of Uncomplicated Chlamydia trachomatis Infections in Adolescents and Adults: Summary of Evidence Reviewed for the 2021 Centers for Disease Control and Prevention Sexually Transmitted Infections Treatment Guidelines.Clin Infect Dis. 2022 Apr 13;74(Suppl_2):S112-S126. doi: 10.1093/cid/ciac126. Clin Infect Dis. 2022. PMID: 35416965 Free PMC article.
-
Point-by-Point Progress: Gonorrhea Point of Care Tests.Expert Rev Mol Diagn. 2020 Aug;20(8):803-813. doi: 10.1080/14737159.2020.1778467. Epub 2020 Jun 30. Expert Rev Mol Diagn. 2020. PMID: 32500764 Free PMC article.
-
The Impact of Selected Bacterial Sexually Transmitted Diseases on Pregnancy and Female Fertility.Int J Mol Sci. 2021 Feb 22;22(4):2170. doi: 10.3390/ijms22042170. Int J Mol Sci. 2021. PMID: 33671616 Free PMC article. Review.
References
-
- Unemo M, Ballard R, Ison C. World Health Organization In: Unemo M, Ballard R, Ison C, editors. Laboratory Diagnosis of Sexually Transmitted Infections, Including Human Immunodeficiency Virus. Geneva, Switzerland: WHO, 2013.
-
- Guy RJ, Causer LM, Klausner JD, Unemo M, Toskin I, Azzini AM, et al. Performance and operational characteristics of point‐of‐care tests for the diagnosis of urogenital gonococcal infections. Sex Transm Infect 2017;93(Suppl 4):16–21. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical